This micro-cap Engineering stock jumped 10 percent after it came out with a press release of successfully manufacturing a fully integrated Rotocone Vacuum Dryer (RCVD) system for the Pharmaceutical (TADAWUL:2070) Industry.
Price Movement
With the market capitalization of Rs 271 crores the share of BEW Engineering Ltd (NSE:BEWE) hit a 10 percent upper circuit of Rs 207.65 compared to previous closing price of Rs 188.80
ProPicks AI is now LIVE in India. ProPicks Strategies utilizes a blend of artificial intelligence (AI) and expert human analysis to spotlight stocks with the potential to outperform market benchmarks. Our Strategies such as Bharat Market Outperformers, Bharat Infra Titans, Bharat Mid-Cap Movers, Bharat Bargains, and Bharat Small Cap Gems have all beaten their respective benchmarks by handsome margins. To view February stock picks by AI, and make use of all other InvestingPro’s features such as Stock Screener, Fair Value, Financial Health, etc., avail Pro+ plan at a 45% discount here.
What Happened
BEW Engineering Ltd has announced it has successfully manufactured a fully integrated Rotocone Vacuum Dryer (RCVD) system with a 3 KL gross capacity, tailored for the high-quality and stringent demands of pharmaceutical and Active Pharmaceutical Ingredient (API) production.RCVD system exemplifies BEW’s commitment to innovation, efficiency, and regulatory compliance in pharmaceutical engineering
About the company
BEW Engineering Limited (“BEW”) is engaged in the design and manufacturing equipments for Pharmaceutical & Chemical plants and process systems. The Company’s major products are Agitated Pressure Nutsche Filter Dryer (ANFD), Rotocone Vacuum Filter Dryers (RVFD), Cantilever Rotocone Vacuum Dryer (RCVD), Retractable Plough Shear Mixer Dryer, Agitated Pan Dryer, Rotary Vacuum Paddle Dryer (RVPD), and Spherical Dryer
The portfolio of products currently includes the design and manufacturing of filters and Dryers for the chemicals industry comprising Agro Chemicals and Pharmaceutical Industries like API, Bulk Drug, and Intermediate Specialty Chemicals.
Financial Highlights
This company reported sales of Rs 51 crore H1FY2025, down by 29 percent from its H1FY24 revenue of Rs 66 crores. It posted a net profit of Rs 6 crores in H1FY2025, up by 50 percent, from its H1FY2024 net profit of Rs 4 crores.
Written by Sanjay G
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses
The post Stock hits 10% upper circuit after successful manufacturing RCVD system for API sector appeared first on Trade Brains.
To subscribe to India’s top stocks in 2025 through ProPicks AI, click here: